Literature DB >> 15631686

Inherited cardiomyopathies as a troponin disease.

K Harada1, S Morimoto.   

Abstract

Troponin, one of the sarcomeric proteins, plays a central role in the Ca(2+) regulation of contraction in vertebrate skeletal and cardiac muscles. It consists of three subunits with distinct structure and function, troponin T, troponin I, and troponin C, and their accurate and complex intermolecular interaction in response to the rapid rise and fall of Ca(2+) in cardiomyocytes plays a key role in maintaining the normal cardiac pump function. More than 200 mutations in the cardiac sarcomeric proteins, including myosin heavy and light chains, actin, troponin, tropomyosin, myosin-binding protein-C, and titin/connectin, have been found to cause various types of cardiomyopathy in human since 1990, and more than 60 mutations in human cardiac troponin subunits have been identified in dilated, hypertrophic, and restrictive forms of cardiomyopathy. In this review, we have focused on the mutations in the genes for human cardiac troponin subunits and discussed their functional consequences that might be involved in the primary mechanisms for the pathogenesis of these different types of cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15631686     DOI: 10.2170/jjphysiol.54.307

Source DB:  PubMed          Journal:  Jpn J Physiol        ISSN: 0021-521X


  13 in total

1.  Recurrent and founder mutations in the Netherlands: mutation p.K217del in troponin T2, causing dilated cardiomyopathy.

Authors:  E Otten; R H Lekanne Dit Deprez; M M Weiss; M van Slegtenhorst; M Joosten; J J van der Smagt; N de Jonge; W S Kerstjens-Frederikse; M T R Roofthooft; A H M M Balk; M P van den Berg; J S Ruiter; J P van Tintelen
Journal:  Neth Heart J       Date:  2010-10       Impact factor: 2.380

2.  Biological actions of green tea catechins on cardiac troponin C.

Authors:  Naoto Tadano; Cheng-Kun Du; Fumiaki Yumoto; Sachio Morimoto; Mika Ohta; Ming-Fang Xie; Koji Nagata; Dong-Yun Zhan; Qun-Wei Lu; Yoshikazu Miwa; Fumi Takahashi-Yanaga; Masaru Tanokura; Iwao Ohtsuki; Toshiyuki Sasaguri
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

3.  Ala scanning of the inhibitory region of cardiac troponin I.

Authors:  Tomoyoshi Kobayashi; Stacey E Patrick; Minae Kobayashi
Journal:  J Biol Chem       Date:  2009-05-29       Impact factor: 5.157

4.  Changes in the dynamics of the cardiac troponin C molecule explain the effects of Ca2+-sensitizing mutations.

Authors:  Charles M Stevens; Kaveh Rayani; Gurpreet Singh; Bairam Lotfalisalmasi; D Peter Tieleman; Glen F Tibbits
Journal:  J Biol Chem       Date:  2017-05-22       Impact factor: 5.157

Review 5.  Biochemical characterisation of Troponin C mutations causing hypertrophic and dilated cardiomyopathies.

Authors:  Athanasia Kalyva; Fragiskos I Parthenakis; Maria E Marketou; Joanna E Kontaraki; Panos E Vardas
Journal:  J Muscle Res Cell Motil       Date:  2014-04-18       Impact factor: 2.698

Review 6.  Single amino acid sequence polymorphisms in rat cardiac troponin revealed by top-down tandem mass spectrometry.

Authors:  Raquel Sancho Solis; Ying Ge; Jeffery W Walker
Journal:  J Muscle Res Cell Motil       Date:  2009-01-23       Impact factor: 2.698

Review 7.  Cardiac Troponins in Dogs and Cats.

Authors:  R Langhorn; J L Willesen
Journal:  J Vet Intern Med       Date:  2015-12-17       Impact factor: 3.333

8.  Topological and organizational properties of the products of house-keeping and tissue-specific genes in protein-protein interaction networks.

Authors:  Wen-Hsien Lin; Wei-Chung Liu; Ming-Jing Hwang
Journal:  BMC Syst Biol       Date:  2009-03-11

9.  Troponin and titin coordinately regulate length-dependent activation in skinned porcine ventricular muscle.

Authors:  Takako Terui; Munguntsetseg Sodnomtseren; Douchi Matsuba; Jun Udaka; Shin'ichi Ishiwata; Iwao Ohtsuki; Satoshi Kurihara; Norio Fukuda
Journal:  J Gen Physiol       Date:  2008-03       Impact factor: 4.086

10.  Familial hypertrophic cardiomyopathy related cardiac troponin C L29Q mutation alters length-dependent activation and functional effects of phosphomimetic troponin I*.

Authors:  Alison Y Li; Charles M Stevens; Bo Liang; Kaveh Rayani; Sean Little; Jonathan Davis; Glen F Tibbits
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.